Cargando…
In situ cancer vaccination using lipidoid nanoparticles
In situ vaccination is a promising strategy for cancer immunotherapy owing to its convenience and the ability to induce numerous tumor antigens. However, the advancement of in situ vaccination techniques has been hindered by low cross-presentation of tumor antigens and the immunosuppressive tumor mi...
Autores principales: | Chen, Jinjin, Qiu, Min, Ye, Zhongfeng, Nyalile, Thomas, Li, Yamin, Glass, Zachary, Zhao, Xuewei, Yang, Liu, Chen, Jianzhu, Xu, Qiaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099179/ https://www.ncbi.nlm.nih.gov/pubmed/33952519 http://dx.doi.org/10.1126/sciadv.abf1244 |
Ejemplares similares
-
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection
por: Ma, Feihe, et al.
Publicado: (2020) -
Study the lipidoid nanoparticle mediated genome editing protein delivery using 3D intestinal tissue model
por: Yang, Tao, et al.
Publicado: (2021) -
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response
por: Chen, Jinjin, et al.
Publicado: (2022) -
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
por: de Groot, Anne Marit, et al.
Publicado: (2018) -
Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs
por: Li, Yamin, et al.
Publicado: (2022)